Clinical Trial Update: VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability, and PK/PD study of VB19055 in healthy Chinese volunteers, with hypertension listed as a condition; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• VB19055

Snippet

Sponsor: Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | Conditions: Hypertension | Phase 1 | Status: RECRUITING